• Exosome Therapeutics market, Size and Share by 2035

    Close to 60 players, worldwide, have taken initiatives to develop exosome therapeutics; the market is characterized by the presence of start-ups and small companies, claims Roots Analysis

    Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade

    A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

     Type of Therapeutic
     Allogeneic Therapy
     AutologousTherapy

     Target Indication(s)
     Degenerative Meniscal Injury
     Dystrophic Epidermolysis Bullosa
     Fistula Perianal
     Retinitis Pigmentosa

     Therapeutic Area
     Dermatological Disorders
     Muscoskeletal Disorders
     Ophthalmic Diseases
     Rectal Disorders


     Route of Administration
     Fistula Tract
     Intra-articular
     Intra-ocular

     Geography
     North America
     Europe
     Asia-Pacific and Rest of the World

    The Exosome Therapeutics Market, 2022-2040 report features the following companies, which we identified to be key players in this domain:
     Codiak BioSciences
     Coya Therapeutics
     Curexsys
     EV Therapeutics
     Evox Therapeutics
     SHIFTBIO
     AEGLE Therapeutics
     AVEM Healthcare
     Cellular Biomedicine Group
     OBCTCD24
     ReNeuron
     Stem Cell Medicine

    Table of Contents

    1. Preface

    2. Executive Summary

    3. Introduction

    4. Market Landscape

    5. Company Profiles

    6. Drug Profiles

    7. Clinical Trial Analysis

    8. Academic Grants Analysis

    9. Global Event Analysis

    10. Partnerships and Collaborations

    11. Funding and Investments

    12. Start-up Health Indexing

    13. Case Study: Exosome Development and Manufacturing Service Providers

    14. Drug Failure Analysis

    15. Market Forecast

    16. Executive Insights

    17. Appendix 1: Tabulated Data

    18. Appendix 2: List of Companies and Organizations

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/exosome-therapeutics-market.html

    You may also be interested in the following titles:
    Decentralized Clinical Trials / Virtual Clinical Trials Market

    Global Antibiotics Market


    You may also like to learn what our experts are sharing in Roots educational series:
    Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?

    Exploring How Artificial Intelligence Is Transforming Digital Pathology


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    Ben.johnson@rootsanalysis.com
    #Exosome Therapeutics Market Trends #Exosome Therapeutics Market Growth #exosometherapies #exosometherapies


    Exosome Therapeutics market, Size and Share by 2035 Close to 60 players, worldwide, have taken initiatives to develop exosome therapeutics; the market is characterized by the presence of start-ups and small companies, claims Roots Analysis Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Therapeutic  Allogeneic Therapy  AutologousTherapy  Target Indication(s)  Degenerative Meniscal Injury  Dystrophic Epidermolysis Bullosa  Fistula Perianal  Retinitis Pigmentosa  Therapeutic Area  Dermatological Disorders  Muscoskeletal Disorders  Ophthalmic Diseases  Rectal Disorders  Route of Administration  Fistula Tract  Intra-articular  Intra-ocular  Geography  North America  Europe  Asia-Pacific and Rest of the World The Exosome Therapeutics Market, 2022-2040 report features the following companies, which we identified to be key players in this domain:  Codiak BioSciences  Coya Therapeutics  Curexsys  EV Therapeutics  Evox Therapeutics  SHIFTBIO  AEGLE Therapeutics  AVEM Healthcare  Cellular Biomedicine Group  OBCTCD24  ReNeuron  Stem Cell Medicine Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Market Landscape 5. Company Profiles 6. Drug Profiles 7. Clinical Trial Analysis 8. Academic Grants Analysis 9. Global Event Analysis 10. Partnerships and Collaborations 11. Funding and Investments 12. Start-up Health Indexing 13. Case Study: Exosome Development and Manufacturing Service Providers 14. Drug Failure Analysis 15. Market Forecast 16. Executive Insights 17. Appendix 1: Tabulated Data 18. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link https://www.rootsanalysis.com/reports/exosome-therapeutics-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market You may also like to learn what our experts are sharing in Roots educational series: Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? Exploring How Artificial Intelligence Is Transforming Digital Pathology About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com Ben.johnson@rootsanalysis.com #Exosome Therapeutics Market Trends #Exosome Therapeutics Market Growth #exosometherapies #exosometherapies
    WWW.ROOTSANALYSIS.COM
    Exosome Therapeutics Market | Industry Analysis | Market Size | 2035
    Exosome therapeutics market, driven by 120+ candidates strong pipeline across 50+ companies, is expected to grow at a rapid growth of over 40% till 2035
    0 Comments 0 Shares 5092 Views
  • mRNA Synthesis and Manufacturing Services market Share, Growth Analysis by 2035

    Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers

    Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035”

    The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes

     A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.
     A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.
     A detailed competitiveness analysis of mRNA custom synthesis service providers.
     A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.
     An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.
     A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.
     A detailed product competitiveness analysis of the mRNA synthesis kits.
     Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).
     Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).
     A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.
     An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022
     An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.
     A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

     Type of Product
     Drug substances (APIs)
     Drug products (FDFs)

     Application Area
     mRNA-based vaccines
     mRNA-based therapeutics

     Therapeutic Area
     Infectious diseases
     Oncological disorders
     Other diseases

     Key Geographical Regions
     North America
     Europe
     Asia-Pacific
     Latin America
     Middle East and North Africa
     Rest of the World

    Key companies covered in the report.
     Aldevron
     APExBIO
     Biomay
     bioSYNTHESIS
     CELLSCRIPT
     eTheRNA
     Eurogentec
     Jena Biosciences
     New England Biolabs
     Thermo Fisher Scientific
     TriLink BioTechnologies

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html

    You may also be interested in the following titles:
    Cannabis Testing Market

    Decentralized Clinical Trials / Virtual Clinical Trials Market


    You may also like to learn what our experts are sharing in Roots educational series:
    Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders

    4D Bioprinting Market: Key Trends


    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    Ben.johnson@rootsanalysis.com

    #mRNASynthesisandManufacturingServicesMarket #mRNASynthesisandManufacturingServicesMarketSize #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts
    mRNA Synthesis and Manufacturing Services market Share, Growth Analysis by 2035 Given the current technical and operational challenges associated with the manufacturing of mRNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the mRNA synthesis and contract manufacturing service providers Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022–2035” The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes  A general overview of mRNA, highlighting details on its structure, the evolution of mRNA vaccines, manufacturing processes and commonly outsourced manufacturing operations.  A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services.  A detailed competitiveness analysis of mRNA custom synthesis service providers.  A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters.  An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.  A detailed overview of the current market landscape of kits available for synthesis of research grade mRNA.  A detailed product competitiveness analysis of the mRNA synthesis kits.  Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio).  Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio).  A detailed assessment of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines.  An insight analysis of the recent partnerships inked between stakeholders engaged in this domain from 2014-2022  An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers.  A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021)  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Product  Drug substances (APIs)  Drug products (FDFs)  Application Area  mRNA-based vaccines  mRNA-based therapeutics  Therapeutic Area  Infectious diseases  Oncological disorders  Other diseases  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa  Rest of the World Key companies covered in the report.  Aldevron  APExBIO  Biomay  bioSYNTHESIS  CELLSCRIPT  eTheRNA  Eurogentec  Jena Biosciences  New England Biolabs  Thermo Fisher Scientific  TriLink BioTechnologies To view more details on this report, click on the link https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html You may also be interested in the following titles: Cannabis Testing Market Decentralized Clinical Trials / Virtual Clinical Trials Market You may also like to learn what our experts are sharing in Roots educational series: Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #mRNASynthesisandManufacturingServicesMarket #mRNASynthesisandManufacturingServicesMarketSize #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts
    WWW.ROOTSANALYSIS.COM
    mRNA Synthesis and mRNA Manufacturing | Market Size | Industry Analysis | 2035
    mRNA synthesis and mRNA manufacturing market, driven by 70+ mRNA manufacturers, is anticipated to gain traction for non-covid mRNA therapeutics in the coming decade
    0 Comments 0 Shares 6192 Views
Sponsored
Sponsored